The designation ARD1B Activators would pertain to a class of compounds that specifically interact with and modulate the function of ARD1B, presuming ARD1B is a protein or enzyme that can be activated by small molecules. In the context of protein nomenclature, ARD could refer to a protein domain or a specific protein that is characterized by ankyrin repeat domains, which are known to mediate protein-protein interactions and are involved in a multitude of cellular functions, such as signaling, cell cycle control, and dynamics of the cytoskeleton. Activators of ARD1B would, therefore, be small molecules that enhance the biological activity of ARD1B, potentially by promoting its association with other proteins, increasing its stability, or facilitating a conformational change that results in its activation. The development of such activators would involve an intricate understanding of the structure and biochemistry of the ARD1B protein, ensuring specificity and effectiveness in modulating its function.
In the process of discovering and characterizing ARD1B activators, researchers would employ a range of scientific techniques. Structural biology methods, such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy, might be utilized to determine the three-dimensional structure of ARD1B, revealing potential druggable sites for the binding of activators. The design of these molecules would be guided by the detailed structural information, focusing on the interaction between the small molecule and specific regions of the protein that are crucial for its activation. Medicinal chemists would synthesize a library of candidate molecules, which would then be tested for their ability to bind to and activate ARD1B in a variety of assays. Biophysical methods, like surface plasmon resonance or isothermal titration calorimetry, could measure the binding kinetics and affinity between ARD1B and potential activators, while in vitro biochemical assays might assess the effects on the protein's activity. Cell-based assays would provide further insights into the compound's ability to modulate ARD1B within a complex biological system. Through these meticulous steps, the specific interaction between ARD1B and its activators could be elucidated, contributing to the fundamental understanding of the protein's role and regulation within cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an HDAC inhibitor that could lead to hyperacetylation of histones, potentially resulting in the upregulation of genes including ARD1B. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may cause demethylation of gene promoters, potentially increasing the expression of genes like ARD1B. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression by activating retinoic acid receptors, which might upregulate ARD1B. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences several signaling pathways including the Wnt pathway, which could potentially affect ARD1B expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could lead to altered protein synthesis and gene expression profiles, potentially including ARD1B. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate can cause changes in chromatin structure and gene expression, potentially including ARD1B. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can affect multiple signaling pathways and may alter the expression of various genes, possibly including ARD1B. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can initiate a variety of cellular responses, potentially altering gene expression such as ARD1B. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As an inducer of oxidative stress, hydrogen peroxide may influence the expression of stress response genes, which could include ARD1B. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylic acid can affect plant stress pathways and could potentially modulate stress-related gene expression in a broader context, including ARD1B. | ||||||